Compounds > 2,5-di-tert-butylhydroquinone

2,5-di-tert-butylhydroquinone and cyclosporine

2,5-di-tert-butylhydroquinone has been researched along with cyclosporine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kmoníčková, E; Peterková, L; Rimpelová, S; Ruml, T1
Okunuki, H; Onose, J; Sawada, J; Teshima, R1

Reviews

1 review(s) available for 2,5-di-tert-butylhydroquinone and cyclosporine

ArticleYear
Sarco/Endoplasmic Reticulum Calcium ATPase Inhibitors: Beyond Anticancer Perspective.
    Journal of medicinal chemistry, 2020, 03-12, Volume: 63, Issue:5

    Topics: Animals; Antineoplastic Agents; Enzyme Inhibitors; Gene Regulatory Networks; Humans; Neoplasms; Protein Structure, Secondary; Sarcoplasmic Reticulum Calcium-Transporting ATPases

2020

Other Studies

1 other study(ies) available for 2,5-di-tert-butylhydroquinone and cyclosporine

ArticleYear
Effect of Ca(2+) ATPase inhibitors on MCP-1 release from bone marrow-derived mast cells and the involvement of p38 MAP kinase activation.
    International archives of allergy and immunology, 2000, Volume: 121, Issue:1

    Topics: Animals; Blotting, Western; Bone Marrow Cells; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Calcium-Transporting ATPases; Chemokine CCL2; Cyclosporine; Dactinomycin; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Inhibitors; Female; Hydroquinones; Indoles; Mast Cells; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors

2000